Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China · Delayed Price · Currency is CNY 15.24
-0.44 (-2.81%)
At close: Nov 13, 2026
SHE:301246 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,564 | 1,939 | 1,771 | 2,055 | 2,064 | 1,578 |
Revenue Growth | 45.20% | 9.53% | -13.83% | -0.43% | 30.79% | 21.10% |
Gross Profit Gross Profit Growth | 539.1 | 324.06 | 180.95 | 240.49 | 442.18 | 526.52 |
Operating Income Operating Income Growth | 305.69 | 116.66 | 35.28 | 63.94 | 261.45 | 356.11 |
Net Income Net Income Growth | 304.39 | 119.05 | 51.47 | 87.17 | 434.8 | 493.85 |
Earnings Per Share EPS Growth | 0.76 | 0.30 | 0.13 | 0.22 | 1.23 | 1.40 |
EPS Growth | 2009.39% | 132.30% | -42.52% | -81.78% | -11.96% | 91.78% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medicine Manufacturing Medicine Manufacturing Growth | 1,007 | 987.39 | - | - | - |
Chemical Raw Materials and Chemical Products Manufacturing Chemical Raw Materials and Chemical Products Manufacturing Growth | 883.05 | 743.36 | - | - | - |
Others Others Growth | 49.53 | 39.97 | 39.5 | 34.45 | 17.7 |
Total Total Growth | 1,939 | 1,771 | 2,055 | 2,064 | 1,578 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,679 | 1,859 | 2,025 | 2,180 | 485.19 | 120.43 |
Total Debt Total Debt Growth | 666.04 | 531.36 | 374.59 | 349.51 | 434.14 | 78.92 |
Net Cash (Debt) Net Cash Growth | 1,013 | 1,328 | 1,651 | 1,831 | 51.05 | 41.51 |
Net Cash Growth | 41.17% | -19.55% | -9.83% | 3485.91% | 22.99% | -62.14% |
Net Cash Per Share Net Cash Per Share Growth | 2.53 | 3.35 | 4.14 | 4.72 | 0.14 | 0.12 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 111.32 | -184.96 | -15.81 | 35.25 | 214.99 | 196.1 |
Capital Expenditures CapEx Growth | -258.38 | -156.09 | -160.2 | -474.64 | -507.09 | -259.01 |
Free Cash Flow Free Cash Flow Growth | -147.06 | -341.06 | -176.01 | -439.39 | -292.1 | -62.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 21.03% | 16.71% | 10.22% | 11.70% | 21.43% | 33.37% |
Operating Margin | 11.92% | 6.02% | 1.99% | 3.11% | 12.67% | 22.57% |
Pretax Margin | 14.63% | 7.51% | 3.37% | 4.80% | 23.16% | 34.54% |
Profit Margin | 11.87% | 6.14% | 2.91% | 4.24% | 21.07% | 31.30% |
FCF Margin | -5.74% | -17.59% | -9.94% | -21.38% | -14.15% | -3.99% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.050 | 0.050 | 0.030 | 0.050 | 0.100 |
Dividend Per Share Growth | 66.67% | 66.67% | -40.00% | -50.00% | - |
Dividend Yield | 0.33% | 0.20% | 0.22% | 0.19% | - |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 20.02 | 83.33 | 104.64 | 119.22 | - | - |
PS Ratio | 2.36 | 5.12 | 3.04 | 5.06 | - | - |